Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓植之后婴儿骨硬化病成骨细胞和破骨细胞活。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨细胞则抑制其溶酶体酶活，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成胞和胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于胞则抑制其溶酶体酶活性，抑制，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成细胞和细胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作细胞则抑制其溶酶体酶活性，抑制吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成胞和胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于胞则抑制其溶酶体酶活性，抑制，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化病成骨破骨活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化病成骨和破骨活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成胞和胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于胞则抑制其溶酶体酶活性，抑制，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴化病成和破性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破则抑制其溶酶体酶性，抑制吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化骨和破骨活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。